{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:57:01Z","timestamp":1771999021584,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ANTIGONE (grant agreement number 278976)"],"award-info":[{"award-number":["ANTIGONE (grant agreement number 278976)"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13567-017-0486-6","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T04:01:10Z","timestamp":1511236870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pigeon paramyxovirus type 1 from a fatal human case induces pneumonia in experimentally infected cynomolgus macaques (Macaca fascicularis)"],"prefix":"10.1186","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-9049","authenticated-orcid":false,"given":"Thijs","family":"Kuiken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Buijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"van Run","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Koopmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"486_CR1","volume-title":"Fields virology","author":"RA Lamb","year":"2013","unstructured":"Lamb RA, Parks GD (2013) Paramyxoviridae. In: Knipe DM, Howley PM (eds) Fields virology. Wolters Kluwer, Philadelphia"},{"key":"486_CR2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/03079457.2011.618823","volume":"40","author":"DJ Alexander","year":"2011","unstructured":"Alexander DJ (2011) Newcastle disease in the European Union 2000\u20132009. Avian Pathol 40:547\u2013558","journal-title":"Avian Pathol"},{"key":"486_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01718397","volume":"141","author":"A Ballagi-Pordany","year":"1996","unstructured":"Ballagi-Pordany A, Wehmann E, Herczeg J, Belak S, Lomniczi B (1996) Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene. Arch Virol 141:243\u2013261","journal-title":"Arch Virol"},{"key":"486_CR4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S0950268802007732","volume":"129","author":"A Czegledi","year":"2002","unstructured":"Czegledi A, Herczeg J, Hadjiev G, Doumanova L, Wehmann E, Lomniczi B (2002) The occurrence of five major Newcastle disease virus genotypes (II, IV, V, VI and VIIb) in Bulgaria between 1959 and 1996. Epidemiol Infect 129:679\u2013688","journal-title":"Epidemiol Infect"},{"key":"486_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s007050050267","volume":"143","author":"B Lomniczi","year":"1998","unstructured":"Lomniczi B, Wehmann E, Herczeg J, Ballagi-Pordany A, Kaleta EF, Werner O, Meulemans G, Jorgensen PH, Mante AP, Gielkens AL, Capua I, Damoser J (1998) Newcastle disease outbreaks in recent years in western Europe were caused by an old (VI) and a novel genotype (VII). Arch Virol 143:49\u201364","journal-title":"Arch Virol"},{"key":"486_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10096-003-1059-3","volume":"23","author":"I Capua","year":"2004","unstructured":"Capua I, Alexander DJ (2004) Human health implications of avian influenza viruses and paramyxoviruses. Eur J Clin Microbiol Infect Dis 23:1\u20136","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"486_CR7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1749-6632.1958.tb35414.x","volume":"70","author":"RP Hanson","year":"1958","unstructured":"Hanson RP, Brandly CA (1958) Newcastle disease. Ann NY Acad Sci 70:585\u2013597","journal-title":"Ann NY Acad Sci"},{"key":"486_CR8","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2460\/javma.2003.222.1534","volume":"222","author":"DE Swayne","year":"2003","unstructured":"Swayne DE, King DJ (2003) Avian influenza and Newcastle disease. J Am Vet Med Assoc 222:1534\u20131540","journal-title":"J Am Vet Med Assoc"},{"key":"486_CR9","volume-title":"Newcastle disease virus, an evolving pathogen","author":"AF Rasmussen","year":"1963","unstructured":"Rasmussen AF (1963) Avian myxoviruses and man. In: Hanson RP (ed) Newcastle disease virus, an evolving pathogen. University of Wisconsin Press, Madison"},{"key":"486_CR10","doi-asserted-by":"crossref","first-page":"12709","DOI":"10.1128\/JVI.01406-07","volume":"81","author":"SJ Goebel","year":"2007","unstructured":"Goebel SJ, Taylor J, Barr BC, Kiehn TE, Castro-Malaspina HR, Hedvat CV, Rush-Wilson KA, Kelly CD, Davis SW, Samsonoff WA, Hurst KR, Behr MJ, Masters PS (2007) Isolation of avian paramyxovirus 1 from a patient with a lethal case of pneumonia. J Virol 81:12709\u201312714","journal-title":"J Virol"},{"key":"486_CR11","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1099\/vir.0.024612-0","volume":"91","author":"S Svraka","year":"2010","unstructured":"Svraka S, Rosario K, Duizer E, van der Avoort H, Breitbart M, Koopmans M (2010) Metagenomic sequencing for virus identification in a public-health setting. J Gen Virol 91:2846\u20132856","journal-title":"J Gen Virol"},{"key":"486_CR12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.meegid.2013.04.025","volume":"17","author":"YL Chong","year":"2013","unstructured":"Chong YL, Lam TT, Kim O, Lu H, Dunn P, Poss M (2013) Successful establishment and global dispersal of genotype VI avian paramyxovirus serotype 1 after cross species transmission. Infect Genet Evol 17:260\u2013268","journal-title":"Infect Genet Evol"},{"key":"486_CR13","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/JVI.73.6.5001-5009.1999","volume":"73","author":"BP Peeters","year":"1999","unstructured":"Peeters BP, de Leeuw OS, Koch G, Gielkens AL (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73:5001\u20135009","journal-title":"J Virol"},{"key":"486_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9975(84)90018-5","volume":"94","author":"S Charan","year":"1984","unstructured":"Charan S, Mahajan VM, Rai A, Balaya S (1984) Ocular pathogenesis of Newcastle disease virus in rabbits and monkeys. J Comp Pathol 94:159\u2013163","journal-title":"J Comp Pathol"},{"key":"486_CR15","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1128\/JVI.79.21.13275-13284.2005","volume":"79","author":"A Bukreyev","year":"2005","unstructured":"Bukreyev A, Huang Z, Yang L, Elankumaran S, St Claire M, Murphy BR, Samal SK, Collins PL (2005) Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol 79:13275\u201313284","journal-title":"J Virol"},{"key":"486_CR16","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1128\/JVI.05050-11","volume":"85","author":"SK Khattar","year":"2011","unstructured":"Khattar SK, Samal S, Devico AL, Collins PL, Samal SK (2011) Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in guinea pigs. J Virol 85:10529\u201310541","journal-title":"J Virol"},{"key":"486_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1297-9716-42-38","volume":"42","author":"AS Samuel","year":"2011","unstructured":"Samuel AS, Subbiah M, Shive H, Collins PL, Samal SK (2011) Experimental infection of hamsters with avian paramyxovirus serotypes 1\u20139. Vet Res 42:38","journal-title":"Vet Res"},{"key":"486_CR18","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench HA (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"486_CR19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/JCM.01625-08","volume":"47","author":"VJ Munster","year":"2009","unstructured":"Munster VJ, Baas C, Lexmond P, Bestebroer TM, Guldemeester J, Beyer WE, de Wit E, Schutten M, Rimmelzwaan GF, Osterhaus AD, Fouchier RA (2009) Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J Clin Microbiol 47:666\u2013673","journal-title":"J Clin Microbiol"},{"key":"486_CR20","doi-asserted-by":"crossref","first-page":"e64892","DOI":"10.1371\/journal.pone.0064892","volume":"8","author":"L Xie","year":"2013","unstructured":"Xie L, Xu F, Liu S, Ji Y, Zhou Q, Wu Q, Gong W, Cheng K, Li J, Li L, Fang L, Zhou L, Xie P (2013) Age- and sex-based hematological and biochemical parameters for Macaca fascicularis. PLoS One 8:e64892","journal-title":"PLoS ONE"},{"key":"486_CR21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.42.1.329-338.2004","volume":"42","author":"MG Wise","year":"2004","unstructured":"Wise MG, Suarez DL, Seal BS, Pedersen JC, Senne DA, King DJ, Kapczynski DR, Spackman E (2004) Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples. J Clin Microbiol 42:329\u2013338","journal-title":"J Clin Microbiol"},{"key":"486_CR22","first-page":"718710","volume":"2011","author":"HY Lam","year":"2011","unstructured":"Lam HY, Yeap SK, Rasoli M, Omar AR, Yusoff K, Suraini AA, Alitheen NB (2011) Safety and clinical usage of Newcastle disease virus in cancer therapy. J Biomed Biotechnol 2011:718710","journal-title":"J Biomed Biotechnol"},{"key":"486_CR23","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1073\/pnas.0703584104","volume":"104","author":"JM DiNapoli","year":"2007","unstructured":"DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A (2007) Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci USA 104:9788\u20139793","journal-title":"Proc Natl Acad Sci USA"},{"key":"486_CR24","doi-asserted-by":"crossref","first-page":"11560","DOI":"10.1128\/JVI.00713-07","volume":"81","author":"JM DiNapoli","year":"2007","unstructured":"DiNapoli JM, Yang L, Suguitan A Jr, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A (2007) Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 81:11560\u201311568","journal-title":"J Virol"},{"key":"486_CR25","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.vaccine.2009.01.009","volume":"27","author":"JM DiNapoli","year":"2009","unstructured":"DiNapoli JM, Ward JM, Cheng L, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A (2009) Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Vaccine 27:1530\u20131539","journal-title":"Vaccine"},{"key":"486_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vaccine.2010.10.024","volume":"29","author":"JM DiNapoli","year":"2010","unstructured":"DiNapoli JM, Yang L, Samal SK, Murphy BR, Collins PL, Bukreyev A (2010) Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine 29:17\u201325","journal-title":"Vaccine"},{"key":"486_CR27","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JVI.01946-09","volume":"84","author":"JM DiNapoli","year":"2010","unstructured":"DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A (2010) Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84:1489\u20131503","journal-title":"J Virol"},{"key":"486_CR28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/cgt.2014.51","volume":"21","author":"PR Buijs","year":"2014","unstructured":"Buijs PR, van Amerongen G, van Nieuwkoop S, Bestebroer TM, van Run PR, Kuiken T, Fouchier RA, van Eijck CH, van den Hoogen BG (2014) Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy. Cancer Gene Ther 21:463\u2013471","journal-title":"Cancer Gene Ther"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-017-0486-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T05:33:56Z","timestamp":1603344836000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryresearch.biomedcentral.com\/articles\/10.1186\/s13567-017-0486-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["486"],"URL":"https:\/\/doi.org\/10.1186\/s13567-017-0486-6","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"article-number":"80"}}